Healthcare -
Biotechnology - NASDAQ - US
$ 1.685
0 %
$ 10.2 M
Market Cap
-0.14
P/E
BTAI - ACCOUNTS PAYABLE
Accounts Payable BTAI - BioXcel Therapeutics, Inc.
16 M
LAST VALUE
25.03%
2 YEAR CAGR
26.41%
5 YEAR CAGR
0.00%
10 YEAR CAGR